Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies
β Scribed by Shin J. Oh; Anjaneyulu Alapati; Gwen C. Claussen; Steven Vernino
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 108 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A young woman presented with facial myokymia in association with dermatomyositis. There was no evidence of peripheral neuropathy. Needle electromyography showed prominent myokymic discharges and brief neuromyotonic discharges in addition to many smallβamplitude, shortβduration motor unit potentials. Myokymia and dermatomyositis both responded to immunosuppressive treatment. The presence of antibodies to voltageβgated potassium channels and the association with dermatomyositis indicated an autoimmune cause for myokymia, which may have been due to reversible peripheral nerve hyperexcitability. Muscle Nerve 27: 757β760, 2003
π SIMILAR VOLUMES
tional voltage
## Abstract The carboxyl terminus of S3 segment (S3~C~) in voltageβgated potassium channels was proposed to bear the binding site for gating modifier toxins like Hanatoxin and a helical secondary structural arrangement was suggested. Due to the lack of complete structure in high resolution for such
Whether P/Q-type voltage-gated calcium channel (VGCC) antibodies are present in the serum of patients with paraneoplastic syndromes other than the Lambert-Eaton myasthenic syndrome (LEMS) and tumors other than small-cell lung cancer (SCLC) is controversial. Using a commercially available radioimmuno